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Supporting Information 
 
 General Information.  Commercial reagents were distilled prior to use following 
the guidelines of Perrin and Armarego (S1).  Organic solutions were concentrated under 
reduced pressure on a Büchi rotary evaporator. Chromatographic purification of products 
was accomplished using forced-flow chromatography on Iatrobeads 6RS–8060 according 
to the method of Still (S2).  Filtration of reactions was perfomed using EMD Silica Gel 
60 230-400 mesh. Thin-layer chromatography (TLC) was performed on EM Reagents 
0.25 mm silica gel 60-F plates.  Visualization of the developed chromatogram was 
performed by fluorescence quenching using anisaldehyde, ceric ammonium molybdenate, 
potassium permanganate or iodine stain.  Supercritical Fluid Chromatography (SFC) and 
Gas liquid chromatography (GLC) assays to determine enantiometric excess were 
developed using racemic samples. 
1H and 13C NMR spectra were recorded on Varian Mercury 300 (300 MHz and 75 
MHz respectively) unless otherwise noted, and are internally referenced to residual protio 
solvent signals.  Data for 1H and 13C NMR are reported as follows: chemical shift (δ 
ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), 
integration, coupling constant (Hz) and assignment.  IR spectra were recorded on a 
Perkin Elmer Spectrum BX FT-IR spectrometer and are reported in terms of frequency of 
absorption (cm-1).  Mass spectra were obtained from the California Institute of 
Technology Mass Spectral facility unless otherwise noted.  Gas liquid chromatography 
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(GLC) was performed on a Hewlett-Packard 6850 Series gas chromatograph equipped 
with a split-mode capillary injection system and flame ionization detectors using a Varian 
Chirasil-Dex-CB (25 m x 0.25 mm) column or Hewlett Packard HP-1 (30m x 0.32mm) 
column.  Supercritical Fluid Chromatography (SFC) was perfomed on a Berger Minigram 
equipped with a variable-wavelength UV detector using a Chiralcel® OJH, ODH and 
Chiralpak®ADH column (25 cm) as noted (4.0 mL/min.).  Optical rotations were 
recorded on a Jasco P-1010 Polarimeter. 
 
General Procedure for the α-Allylation of Aldehydes:  To an oven-dried 25 
mL round-bottom flask equipped with a magnetic stir bar and charged with (2S,5S)-5-
benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one trifluoroacetic acid salt 1 (72 mg, 0.20 
mmol), ceric ammonium nitrate (CAN) (1.37g, 2.5 mmol) and oven-dried sodium 
bicarbonate (126 mg, 1.5 mmol) was added dimethoxyethane (S3) (DME) (4.0 mL).  The 
suspension was cooled to –50 ºC and deoxygenated by stirring vigorously under vacuum 
for 3-5 min (S4).  The mixture was back-filled with argon and degassed twice more.  The 
allyltrimethylsilane substrate (2.5 mmol) was added followed by the aldehyde substrate 
(1.0 mmol).  The reaction was warmed to –20 ºC and stirred for 24 h under an argon 
atmosphere.  The reaction was then cooled to –50 ºC and quickly filtered through a pad of 
silica gel, eluting with Et2O.  The flask was washed with a minimal amount of DME to 
transfer any remaining yellow solid to the silica pad.  The filtrate was concentrated in 
vacuo and purified by forced flow chromatography to afford the title compounds. The 
enantioselectivity was determined either by chiral GLC analysis or chiral SFC analysis 
after reduction to the primary alcohol and acylation with 2-naphthoylchloride.   
 
α-Allyl Aldehydes 
 
H Me
O
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 (R)-2-Allyloctanal (Table 1, entry 1): Prepared according to the general 
procedure from octanal (156 µL, 1.00 mmol) to afford a yellow oil.  Purification on 
Iatrobeads (2-10% Et2O/Pentanes) afforded (R)-2-allyloctanal as a colorless oil (137 mg, 
81% yield, 91% ee).  IR (film) 3075, 2928, 2858, 2703, 1728, 1708, 1641, 1458, 992.6, 
915.5, 724.0 cm-1; 1H NMR (300 MHz, acetone-d6) δ 9.59 (d, J = 2.4 Hz, 1H, CHO), 
5.69-5.84 (m, 1H, CH=CH2), 4.97-5.10 (m, 2H, CH=CH2), 2.30-2.46 (m, 2H, 
CHCH2CH, CHCHO), 2.17-2.28 (m, 1H, CHCH2CH), δ 1.38-1.72 (dm, 2H, CH2(CH2)4), 
1.20-1.38 (m, 8H, CH2(CH2)4), 0.87 (t, J = 6.9 Hz, 3H, CH3); 13C NMR (75 MHz, 
acetone-d6) δ 204.7, 136.4, 116.9, 51.7, 33.5, 32.2, 29.9, 28.8, 27.4, 23.1, 14.2.  HRMS 
(EI+) exact mass calculated for [M-H]+ (C11H20O) requires m/z 168.1514, found m/z 
168.1508.  [α]D = +12.7 (c = 1.0, CHCl3).  Enantiopurity was determined by GLC using a 
Varian Chirasil-Dex-CB (25 m x 0.25 mm) column (100 °C isotherm);  (S) isomer tr = 
23.2 min and (R) isomer tr = 23.8 min. 
 
 
H
O
 
 
(R)-2-Allyl-undec-10-enal (Table 1, entry 2):  Prepared according to the general 
procedure from undecylenic aldehyde (200 µL, 1.00 mmol) to afford a yellow oil.  
Purification on Iatrobeads (2-10% Et2O/Pentanes) afforded (R)-2-allyl-undec-10-enal as a 
colorless oil (156 mg, 75% yield, 92% ee).  IR (film) 3077, 2927, 2855, 2704, 1728, 
1641, 1441, 993.1, 912.1, 721.4 cm-1; 1H NMR (300 MHz, acetone-d6) δ 9.59 (d, J = 2.2 
Hz, 1H, CHO), 5.69-5.86 (m, 2H, CHCH2CH=CH2, CH2CH2CH=CH2), 4.86-5.10 (m, 
4H, CHCH2CH=CH2, CH2CH2CH=CH2), 2.30-2.46 (m, 2H, CHCH2CH, 
CHCHO), 2.17-2.28 (m, 1H, CHCH2CH), 1.98-2.06 (m, 2H, CH2CH2CH=CH2), 1.20-
1.72 (m, 12H, CH(CH2)6); 13C NMR (75 MHz, acetone-d6) δ 204.7, 139.7, 136.5, 116.9, 
114.6, 51.7, 34.4, 33.5, 29.9, 29.6, 29.5, 28.8, 27.5.  HRMS (FAB+) exact mass 
calculated for [M+•]+ (C14H24O) requires m/z 208.1827, found m/z 208.1822.  [α]D = 
+12.1 (c = 1.0, CHCl3). Enantiopurity was determined by SFC analysis after reduction to 
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the primary alcohol and acylation with 2-naphthoylchloride. (Chiralcel®OJH 5% Isocratic 
MeCN).  tS(minor) = 3.9 min.  tR(major) = 4.4 min. 
 
H
O
OBz
 
 
(R)-9-Formyldodec-11-enyl benzoate (Table 1, entry 3):  Prepared according to 
the general procedure from 9-formylnonyl benzoate (138 mg, 0.5 mmol) to afford a 
yellow oil.  Purification on Iatrobeads (10-50% Et2O/Pentanes) afforded (R)-9-
formyldodec-11-enyl benzoate as a colorless oil (114 mg, 72% yield, 95% ee).  IR (film) 
3077, 2927, 2855, 2704, 1728, 1641, 1441, 993.1, 912.1, 721.4 cm-1; 1H NMR (300 
MHz, acetone-d6) δ 9.59 (d, J = 2.1 Hz, 1H, CHO), 7.99-8.04 (m, 2H, Ph), 7.59-7.66 (m, 
1H, Ph), 7.47-7.54 (m, 2H, Ph), 5.69-5.84 (m, 1H, CH=CH2), 4.97-5.10 (m, 2H, 
CH=CH2), 4.30 (t, J = 6.5 Hz, 2H, CH2OBz), 2.30-2.46 (m, 2H, CHCH2CH, CHCHO), 
2.17-2.28 (m, 1H, CHCH2CH), 1.20-1.82 (m, 14H, (CH2)7CH2OBz); 13C NMR (75 MHz, 
acetone-d6) δ 204.7, 166.6, 136.5, 133.7, 131.4, 130.0, 129.3, 116.9, 65.4, 51.7, 33.5, 
30.2, 29.9, 29.8, 29.3, 28.8, 27.4, 26.6.  HRMS (EI+) exact mass calculated for [M+•]+ 
(C20H28O3) requires m/z 316.2039, found m/z 316.2041.  [α]D = +5.8 (c = 1.0, CHCl3). 
Enantiopurity was determined by SFC analysis after acetal formation with (R,R)-
pentadiol of both (R)-9-formyldodec-11-enyl benzoate and (S)-9-formyldodec-11-enyl 
benzoate, separately. (Chiralcel®ODH 5-10% MeCN).  (R,R,S) isomer tr = 6.2 min and 
(R,R,R) isomer tr = 6.9 min.  
 
9-Formylnonyl Benzoate:  A solution of 10-hydroxydecyl benzoate (2.9 g, 10.4 
mmol) in dichloromethane (DCM) (40 mL) was cooled to 0 ºC and pyridinium 
chlorochromate (PCC) was added (3.4 g, 15.6 mmol).  The reaction was warmed to 
ambient temperature and stirred for 4 h.  The reaction was filtered through Florisil®, 
washing with Et2O and concentrated in vacuo.  Purification by forced flow 
chromatography (30% Et2O/Pentanes) affored the title compound (1.58 g, 55% yield). IR 
(film) 2922, 2851, 1714, 1451, 1386, 1309, 1269, 1173, 1105, 1070, 1024, 708 cm-1; 1H 
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NMR (600 MHz, CDCl3) δ 9.77 (t, J = 1.83 Hz, 1H, CHO), 8.04-8.06 (m, 2H, ortho-
phenyl), 7.54-7.58 (m, 1H, para-phenyl), 7.43-7.46 (m, 2H, meta-phenyl), 4.32 (t, J = 
6.78 Hz, 2H, CH2OC(O)Ph), 2.34-2.44 (m, 2H, CH2CHO), 1.75-1.79 (m, 2H, 
CH2CH2OC(O)Ph), 1.62-1.65 (m, 2H, CH2CH2CHO), 1.33-1.47 (m, 10H, 
CH2(CH2)5CH2); 13C NMR (125 MHz, acetone-d6) δ 202.9, 166.7, 133.8, 131.5, 130.1, 
129.4, 64.6, 44.3, 34.2, 30.1, 30.0, 29.9, 26.8, 25.7, 22.7.  HRMS (EI+) exact mass 
calculated for [M+H]+ (C17H25O3) requires m/z 277.1804, found m/z 277.1795 (S4). 
 
10-Hydroxydecyl benzoate:  To a solution of 1,10-decanediol (5.0 g, 28.7 mmol) 
in 100 mL of tetrahydrofuran (THF) was added triethylamine (TEA) (4.8 mL, 34.4 
mmol) and the reaction mixture was cooled to 0 ºC.  Benzoyl chloride (1.7 mL, 14.3 
mmol) was slowly added and the reaction mixture was stirred at 0 ºC for 45 min. then at 
ambient temperature overnight.  The reaction was concentrated in vacuo until 15 mL of 
solvent remained, then filtered and washed with Et2O.  The filtrate was concentrated in 
vacuo and filtered a second time, and the filtrate purified by forced flow chromatography 
(30-100% Et2O/Pentanes) (2.91 g, 73% yield).  IR (film) 3362, 2922, 2851, 1717, 1451, 
1383, 1312, 1269, 1173, 1110, 1067, 1024, 706 cm-1; 1H NMR (400 MHz, acetone-d6) δ 
8.04 (dd, J = 8.4 Hz, 1.2 Hz, 2H, ortho-phenyl), 7.62-7.66 (m, 1H, para-phenyl), 7.50-
7.55 (m, 2H, meta-phenyl), 4.32 (t, J = 6.8 Hz, 2H, CH2OC(O)Ph), 3.51-3.55 (m, 2H, 
CH2OH), 3.38-3.44 (m, 1H, OH), 1.75-1.82 (m, 2H, CH2CH2OC(O)Ph), 1.31-1.54 (m, 
14H, (CH2)7CH2OH; 13C NMR (125 MHz, CDCl3) δ 166.9, 133.0, 130.7, 129.7, 128.5, 
65.3, 63.3, 33.0, 29.7, 29.6 29.6, 29.4, 28.9 26.2, 25.9.  HRMS (EI+) exact mass 
calculated for [M+•]+ (C17H26O3) requires m/z 278.1882, found m/z 278.1879 (S5). 
 
H
O
Me
O
 
 
(R)-2-Allyl-6-oxoheptanal (Table 1, entry 4): Prepared according to the general 
procedure from 6-oxoheptanal (S6) (128 mg, 1.0 mmol) to afford a yellow oil.  
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Purification on Iatrobeads (20-60% Et2O/Pentanes) afforded (R)-2-allyl-6-oxoheptanal as 
a colorless oil (121 mg, 72% yield, 87% ee).  IR (film) 3418, 3079, 2931, 2862, 2720, 
1718, 1642, 1416, 1361, 1164, 996.4, 919.5, 725.7 cm-1; 1H NMR (300 MHz, acetone-d6) 
δ 9.60 (d, J = 2.1 Hz, 1H, CHO), 5.69-5.84 (m, 1H, CH=CH2), 4.97-5.11 (m, 2H, 
CH=CH2), 2.46 (t, J = 6.9 Hz, 2H, CH2OCH3), 2.32-2.44 (m, 2H, CHCH2CH, CHCHO), 
2.18-2.28 (m, 1H, CHCH2CH), 2.06 (s, 3H, CH3), 1.39-1.68 (m, 4H, CH(CH2)2); 13C 
NMR (75 MHz, acetone-d6) δ 207.6, 204.6, 136.3, 117.0, 51.6, 43.4, 33.4, 29.6, 28.1, 
21.6.  HRMS (EI+) exact mass calculated for [M+•]+ (C10H16O2) requires m/z 168.1150, 
found m/z 168.1149.  [α]D = –8.0 (c = 1.0, CHCl3). Enantiopurity was determined by 
GLC analysis after acetal formation with (R,R)-pentadiol of both (R)-2-allyl-6-
oxoheptanal and (S)-2-allyl-6-oxoheptanal, separately. Varian Chirasil-Dex-CB (25M x 
0.25mm) column (115 0C isotherm); (R,R,R) isomer tr = 93.5 min and (R,R,S) isomer tr = 
96.6 min.   
 
H
O
 
 
 (S)-2-Cyclohexylpent-4-enal (Table 1, entry 5): Prepared according to the 
general procedure from 2-cyclohexylacetaldehyde (15.6 mg, 0.125 mmol) and methyl 
cyclohexanecarboxylate (19.9 mg, 0.140 mmol) as an internal standard (75% GC yield, 
94% ee).  Purification on Iatrobeads for characterization (10-50% Et2O/Pentanes) 
afforded (S)-2-cyclohexylpent-4-enal as a volatile colorless oil containing Et2O.  IR 
(film) 3078, 2927, 2854, 2706, 1726, 1642, 1449, 994.1, 914.8, 851.6 cm-1; 1H NMR 
(300 MHz, acetone-d6) δ 9.62 (d, J = 2.7 Hz, 1H, CHO), 5.68-5.81 (m, 1H, CH=CH2), 
4.94-5.08 (m, 2H, CH=CH2), 2.36-2.47 (m, 1H, CHCH2CH), 2.16-2.30 (m, 2H, 
CHCH2CH, CHCHO), 1.60-1.78 and 1.02-1.33 (m, 11H, cyclohexyl);  13C NMR (75 
MHz, acetone-d6) δ 205.0, 137.1, 116.5, 57.4, 38.4, 31.1, 30.8, 30.6, 27.0, 27.0, 26.8.  
HRMS (EI+) exact mass calculated for [M+•]+ (C11H18O) requires m/z 166.1358, found 
m/z 166.1361.  [α]D = +33.9 (c = 1.0, CHCl3). Enantiopurity was determined by GLC 
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using a Varian Chirasil-Dex-CB (25 m x 0.25 mm) column (100 °C isotherm);  (S) 
isomer tr = 36.3 min and (R) isomer tr = 37.7 min. 
 
H
O NBoc
 
 
 tert-Butyl 4-((S)-1-formylbut-3-enyl)piperidine-1-carboxylate (Table 1, entry 
6): Prepared according to the general procedure from tert-butyl 4-
(formylmethyl)piperidine-1-carboxylate (S7) (114 mg, 0.5 mmol) to afford a yellow oil.  
Purification on Iatrobeads (25-50% Et2O/Pentanes) afforded tert-butyl 4-((S)-1-
formylbut-3-enyl)piperidine-1-carboxylate as a colorless oil (94 mg, 70% yield, 93% ee).  
IR (film) 2977, 2932, 2854, 2713, 1726, 1692, 1423, 1366, 1281, 1249, 1172, 918.0, 
866.6, 769.3 cm-1; 1H NMR (300 MHz, acetone-d6) δ 9.65 (d, J = 2.7 Hz, 1H, CHO), 
5.69-5.84 (m, 1H, CH=CH2), 4.98-5.10 (m, 2H, CH=CH2), 4.08 (bs, 2H, 
(CHaHb)2NBoc), 2.67 (bs, 2H, (CHaHb)2NBoc), 2.24-2.46 (m, 3H, CHCH2CH, 
CHCHO), 1.84-1.98 (m, 1H, CHCHCHO), 1.58-1.72 (m, 2H, (CHaHbCH2)2NBoc), 1.41 
(s, 9H, (CH3)3), 1.13-1.31 (m, 2H, (CHaHbCH2)2NBoc); 13C NMR (75 MHz, acetone-d6) 
δ 204.7, 154.8, 136.7, 116.9, 79.1, 56.5, 36.5, 30.8, 28.4.  HRMS (EI+) exact mass 
calculated for [M-H]+ (C15H24NO3) requires m/z 266.1756, found m/z 266.1762.  [α]D = 
+7.8 (c = 1.0, CHCl3). Enantiopurity was determined by SFC analysis after reduction to 
the primary alcohol and acylation with 2-naphthoylchloride. (Chiralcel®ODH 5-50% 
MeCN).  tR(major) = 5.9 min.  tS(minor) = 6.2 min. 
 
H Me
O
Me
 
 
 (R)-2-(2-Methylallyl)octanal (Table 1, entry 7): Prepared according to the 
general procedure from octanal (156 µL, 1.00 mmol)  and methallyltrimethylsilane 
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(440µL, 2.50 mmol) to afford a yellow oil.  Purification on Iatrobeads (2-10% 
Et2O/Pentanes) afforded (R)-2-(2-methylallyl)octanal as a colorless oil (160 mg, 88% 
yield, 91% ee).  IR (film) 3075, 2929, 2857, 2703, 1729, 1651, 1456, 1377, 892.5, 724.0 
cm-1; 1H NMR (300 MHz, acetone-d6) δ 9.56 (d, J = 2.7 Hz, 1H, CHO), 4.74-4.77 (m, 
1H, C=CHaHb), 4.70-4.72 (m, 1H, C=CHaHb), 2.35-2.52 (m, 2H, CHCH2C=, 
CHCHO), 2.10-2.16 (m, 1H, CHCH2C=), 1.70 (s, 3H, CCH3), 1.40-1.66 (dm, 2H, 
CH2(CH2)4), 1.22-1.34 (m, 8H, CH2(CH2)4), 0.86 (t, J = 6.6 Hz, 3H, CH3); 13C NMR (75 
MHz, acetone-d6) δ 204.9, 143.7, 112.6, 50.1, 37.7, 32.3, 29.3, 27.5, 23.1, 22.3, 14.2.  
HRMS (EI+) exact mass calculated for [M+•]+ (C12H22O) requires m/z 182.1671, found 
m/z 182.1663.  [α]D = +14.5 (c = 1.0, CHCl3).  Enantiopurity was determined by GLC 
using a Varian Chirasil-Dex-CB (25 m x 0.25 mm) column (100 °C isotherm);  (S) 
isomer tr = 35.4 min and (R) isomer tr = 36.1 min.   
 
H Me
O
Ph
 
 
(R)-2-(2-Phenylallyl)octanal (Table 1, entry 8): Prepared according to the 
general procedure from octanal (156 µL, 1.00 mmol) and trimethyl(2-phenylallyl)silane 
(S8): (476 mg, 2.50 mmol) to afford a yellow oil.  Purification on Iatrobeads (3-30% 
Et2O/Pentanes) afforded (R)-2-(2-phenylallyl)octanal as a colorless oil (213 mg, 87% 
yield, 90% ee).  IR (film) 3082, 3057, 3025, 2955, 2929, 2857, 2710, 1727, 1628, 1600, 
1574, 1495, 1456, 1378, 1303, 1076, 1028, 900.6, 778.7, 705.8 cm-1; 1H NMR (300 
MHz, acetone-d6) δ 9.58 (d, J = 2.7 Hz, 1H, CHO), 7.12-7.30 (m, 5H, Ph), 5.32 (d, J = 
1.3 Hz, 1H, C=CHaHb), 5.13 (q, J = 1.3 Hz, 1H, C=CHaHb), 2.96 (ddd, J = 14.6 Hz, 7.4 
Hz, 1.3 Hz, 1H, CHOCHCHaHb), 2.63 (ddd, J = 14.6 Hz, 6.9 Hz, 1.1 Hz, 1H, 
CHOCHCHaHb), 2.31-2.42 (m, 1H, CHCHO), 1.42-1.68 (m, 2H, CH2(CH2)4), 1.18-1.34 
(m, 8H, CH2(CH2)4), 0.84 (t, J = 7.2 Hz, 3H, CH3); 13C NMR (75 MHz, acetone-d6) δ 
204.5, 147.0, 141.3, 129.2, 128.4, 127.0, 114.7, 50.4, 35.2, 32.2, 29.9, 29.0, 27.2, 23.1, 
14.2.  HRMS (EI+) exact mass calculated for [M+•]+ (C17H24O) requires m/z 244.1827, 
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found m/z 244.1837.  [α]D = +13.4 (c = 1.0, CHCl3).  Enantiopurity was determined by 
SFC analysis after reduction to the primary alcohol. (Chiralcel®OJH 2-5% IPA).  
tR(major) = 5.2 min.  tS(minor) = 6.1 min. 
 
H Me
O
Ph
 
 
(R)-2-Hexyl-4-phenethyl-pent-4-enal (Table 1, entry 9):  Prepared according to 
the general procedure from octanal (156 µL, 1.00 mmol) and trimethyl(2-methylene-4-
phenylbutyl)silane (S9) (546 mg, 2.50 mmol) to afford a yellow oil.  Purification on 
Iatrobeads (3-30% Et2O/Pentanes) afforded (R)-2-hexyl-4-phenethyl-pent-4-enal as a 
colorless oil (209 mg, 77% yield, 88% ee).  IR (film) 3085, 3027, 2955, 2929, 2857, 
2708, 1727, 1645, 1604, 1496, 1454, 1077, 1031, 895.9, 747.2, 698.7 cm-1; 1H NMR (300 
MHz, acetone-d6) δ 9.57 (d, J = 2.9 Hz, 1H, CHO), 7.13-7.30 (m, 5H, Ph), 4.84 (app. d, J 
= 1.3 Hz, 1H, C=CHaHb), 4.79 (app. d, J = 1.1 Hz, 1H, C=CHaHb), 2.76 (dd, J = 8.2 Hz, 
8.0 Hz, 2H, CH2Ph), 2.14-2.57 (m, 5H, CHCHO, CHCH2C=C, CH2CH2Ph), 1.38-1.68 
(dm, 2H, CH2(CH2)4), 1.20-1.38 (m, 8H, CH2(CH2)4), 0.86 (t, J = 6.9 Hz, 3H, CH3); 13C 
NMR (75 MHz, acetone-d6) δ 204.9, 147.2, 142.7, 129.1, 129.0, 126.5, 112.0, 50.2, 38.3, 
36.1, 34.8, 32.3, 29.4, 27.5, 23.1, 14.2.  HRMS (EI+) exact mass calculated for [M+•]+ 
(C19H28O) requires m/z 272.2140, found m/z 272.2129.  [α]D = +11.6 (c = 1.0, CHCl3).  
Enantiopurity was determined by SFC analysis after reduction to the primary alcohol and 
acylation with 2-naphthoylchloride.  (Chiralpak®ADH 2-25% IPA).  tS(minor) = 7.4 min.  
tR(major) = 7.8 min. 
 
H Me
O
CO2Et
 
 
(R)-Ethyl 4-formyl-2-methylenedecanoate (Table 1, entry 10):  Prepared 
according to the general procedure from octanal (156 µL, 1.00 mmol) to afford a yellow 
oil.  Purification on Iatrobeads (10-50% Et2O/Pentanes) afforded (R)-ethyl 4-formyl-2-
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methylenedecanoate as a colorless oil (194 mg, 81% yield, 90% ee).  IR (film) 2930, 
2858, 2712, 1720, 1630, 1466, 1370, 1302, 1185, 1153, 1027, 948.7, 854.3, 818.8, 724.7 
cm-1; 1H NMR (300 MHz, acetone-d6) δ 9.58 (d, J = 2.7 Hz, 1H, CHO), 6.16 (d, J = 1.3 
Hz, 1H, C=CHaHb), 5.66 (d, J = 1.3 Hz, 1H, C=CHaHb), 4.16 (q, J = 7.2 Hz, 2H, 
OCH2CH3), 2.64-2.73 (m, 1H, CHaHbC=CH2), 2.47-2.58 (m, 1H, CHCHO), 2.37-2.45 
(m, 1H, CHaHbC=CH2), 1.38-1.72 (dm, 2H, CH2(CH2)4), 1.26 (t, J = 7.2 Hz, 3H, 
OCH2CH3), 1.22-1.36 (m, 8H, CH2(CH2)4), 0.86 (t, J = 6.6 Hz, 3H, CH3); 13C NMR (75 
MHz, acetone-d6) δ 204.3, 166.9, 139.2, 126.9, 61.1, 51.2, 32.2, 31.8, 29.9, 29.2, 27.4, 
23.1, 14.3, 14.2.  HRMS (EI+) exact mass calculated for [M-H]+ (C14H23O3) requires m/z 
239.1647, found m/z 239.1659.  [α]D = +13.0 (c = 1.0, CHCl3).  Enantiopurity was 
determined by achiral GLC after acetal formation with (R,R)-pentanediol and (S,S)-
pentanediol, separately.  Hewlett Packard HP-1 (30 m x 0.32 mm) column (140 °C 
isotherm);  (R,R,R) and (S,S,S) isomer tr = 91.5 min and (R,R,S) and (S,S,R) isomer tr = 
93.7 min. 
 
Determination of Absolute Stereochemistry 
 
HO Me
O
 
 (R)-2-Allyloctanoic acid:  To a flask containing (R)-2-allyloctanal (45 mg, 0.267 
mmol, 91% ee) and dissolved in tert-butanol (800 µL) and water (300 µL) at 0 ºC was 
added sodium dihydrogenphosphate hydrate (9.2 mg, 0.067 mmol) followed by 2-methyl-
2-butene (124 µL, 1.17 mmol).  Separately, sodium chlorite (42 mg, 0.374 mmol) was 
dissolved in water (500 µL) and cooled to 0 ºC, and the solution added to the aldehyde 
solution.  The reaction was allowed to warm to ambient temperature over 4 h.  Saturated 
sodium sulfite (1.00 mL) was added and stirred vigorously 5 min.  The reaction was 
acidified to pH~2, extracted with Et2O (3 x 25 mL), and dried over Na2SO4.  Purification 
by forced flow chromatography on Iatrobeads (5-50% Et2O/Pentanes) afforded a 
colorless oil (31 mg, 63% yield), which corresponded to the reported literature compound 
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(S10).  [α]D = +12.7 (c = 1.0, EtOH), Lit. (S)-2-allyloctanoic acid [α]D = –11.1 (c = 1.0, 
EtOH).   
 
HO
O
Me
 
 (R)-2-Allylnonanoic acid:  Prepared according to the oxidation procedure for 
(R)-2-allyloctanoic acid from (R)-2-allylnonanal (S11) (45 mg, 0.250 mmol, 91% ee). 
Purification by forced flow chromatography on Iatrobeads (5-50% Et2O/Pentanes) 
afforded a colorless oil (37 mg, 76% yield).  Spectral data for the title compound matched 
the reported literature compound (S12).  [α]D = +5.99 (c = 1.0, CHCl3), Lit. (S)-2-
allylnonanoic acid [α]D = –8.1 (c = 2.78, CHCl3).   
 
HO
O NBoc
 
 (S)-2-(1-tert-Butoxycarbonyl)piperidin-4-yl)pent-4-enoic acid: Prepared 
according to the oxidation procedure for (R)-2-allyloctanoic acid from tert-butyl 4-((S)-1-
formylbut-3-enyl)piperidine-1-carboxylate (52 mg, 0.194 mmol, 93% ee).  The reaction 
was extracted with EtOAc (3 x 25 mL) in place of Et2O (40 mg, 73% yield).  IR (film) 
3073, 2977, 2934, 2861, 1733, 1659, 1428, 1367, 1282, 1249, 1167, 1138, 993.8, 916.7, 
866.4, 766.3 cm-1; 1H NMR (400 MHz, acetone-d6) δ 5.74-5.85 (m, 1H, CH=CH2), 4.96-
5.10 (m, 2H, CH=CH2), 4.08 (bs, 2H, (CHaHb)2NBoc), 2.67 (bs, 2H, (CHaHb)2NBoc), 
2.24-2.38 (m, 3H, CHCH2CH, CHCHO), 1.58-1.80 (m, 3H, (CHaHbCH2)2NBoc, 
CHCHCHO), 1.41 (s, 9H, (CH3)3), 1.10-1.32 (m, 2H, (CHaHbCH2)2NBoc); 13C NMR 
(Bruker Avance II 500, APT experiment, 125 MHz, acetone-d6) δ 176.2, 155.8, 137.8, 
117.6, 80.1, 52.1, 39.6, 35.1, 31.4, 29.4.  HRMS (FAB+) exact mass calculated for 
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[M+H]+ (C15H26NO4) requires m/z 284.1862, found m/z 284.1872. [α]D = +12.23 (c = 1.0, 
EtOH). 
 
HO
O NBoc
N
O NBoc
O
O
Bn
N
O NBoc
O
O
Bn
HO
O NBoc
i) pivaloyl chloride, TEA, THF
ii) (R)-4-benzyloxazolidin-2-one,
LiCl
i) NaHMDS, THF, –78 ºC
ii) allylbromide, –20 ºC
LiOH, H2O2, 0 ºC
2 3
4 5  
 (R)-2-(1-tert-Butoxycarbonyl)piperidin-4-yl)pent-4-enoic acid: tert-Butyl 4-
(formylmethyl)piperidine-1-carboxylate (S6) (500 mg, 2.2 mmol) was converted to the 
corresponding carboxylic acid 2 using the procedure described for (R)-2-allyloctanoic 
acid (473 mg, 88% yield).   
The carboxylic acid 2 was converted to the 4-[2-((R)-4-benzyl-2-oxo-oxazolidin-
3-yl)-2-oxo-ethyl]-piperidine-1-carboxylic acid tert-butyl ester 3 in like manner as 
described by Fuwa et al (S13).  The carboxylic acid 2 (217 mg, 0.89 mmol) was 
dissolved in dry THF (7.0 mL) and TEA (248 µL, 1.78 mmol) and cooled to –78 ºC.  
Pivaloyl chloride (132 µL, 1.07 mmol) was added and the reaction was gradually warmed 
to 0 ºC over 90 min.  (R)-4-benzyloxazolidin-2-one (158 mg, 0.89 mmol) was added 
followed by lithium chloride (113 mg, 2.67 mmol) and the reaction was warmed to 
ambient temperature and stirred overnight.  The reaction was diluted with ethyl acetate 
(EtOAc) (25 mL) and washed with water (10 mL), brine (10 mL), dried over Na2SO4, 
filtered and concentrated in vacuo.  Purification by forced flow chromatography (silica 
gel, 10-50% EtOAc/Hexanes) afforded 3 (215 mg, 60% yield). 
Allylation of 3 was performed in like manner to Evans et al. (S14), 3 (172 mg, 
0.427 mmol) was dissolved in THF (4 mL) and cooled to –78 ºC. NaN(SiMe3)2 (641 µL, 
0.64 mmol) was added and the reaction was stirred for 1 h.  Allylbromide (145 µL, 1.71 
mmol) was then added and the reaction was warmed to –20 ºC over 6 h.  A saturated 
NH4Cl solution (5 mL) was added and the reaction stirred overnight.  The reaction was 
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diluted with EtOAc (25 mL) and washed with saturated aqueous NH4Cl (10 mL), and 
brine (10 mL).  Dried over Na2SO4, filtered and concentrated in vacuo.  Purification by 
forced flow chromatograpy (silica gel, 5-50% EtOAc/hexanes) affored 4-[(R)-1-((R)-4-
benzyl-2-oxo-oxazolidine-3-carbonyl)-but-3-enyl]-piperidine-1-carboxylic acid tert-butyl 
ester 4 (60 mg, 32% yield). 
The allylated oxazolidinone 4 was converted to the title compound 5 in like 
manner to the method of  Stončius et al. (S15)  4 (40 mg, 0.09 mmol) was dissolved in 
THF (1 mL) and cooled to 0 ºC.  H2O2 (30% aqueous, 44 µL, 0.39 mmol) was added 
dropwise followed by a solution of LiOH hydrate (8.4 mg, 0.20 mmol) in water (500 µL).  
Stirring was continued at 0 ºC for 3 h.  Saturated Na2SO3 (500 µL) and saturated 
NaHCO3 (500 µL) aqueous solutions were added and the mixture stirred vigorously 
allowing to warm to ambient temperature overnight.   The reaction was acidified with 1N 
HCl to pH~2, and extracted with EtOAc (3 x 10 mL).  Dried over Na2SO4, filtered and 
concentrated in vacuo to afford the title compound 5 (20 mg, 80% yield).  Spectral data 
was identical to the (S)-enantiomer synthesized above.  [α]D = –11.07 (c = 1.0, EtOH). 
 
 
H Me
O
OMe
O2NO
 
2-((E)-4-methoxy-5-nitrooxy-5-phenylpent-2-enyl)octanal (Figure 3c):  
Prepared according to the general procedure, in acetone-d6 with water (18mg, 1.0 mmol), 
from octanal (78 µl, 0.5 mmol) and (trans, trans-2-methoxy-3-
phenylcyclopropyl)ethylene (S16) to afford a yellow oil.  Purification on Iatrobeads (5-
50% Et2O/Pentanes) afforded 2-((E)-4-methoxy-5-nitrooxy-5-phenylpent-2-enyl)octanal 
as a colorless oil.  The product obtained is a 2 : 1 : 1 : 0.5 mixture of diastereomers.  Data 
reported  for  the major diastereomer only.  1H NMR (400 MHz, acetone-d6) δ 9.59 (d, 
1H, J = 2.4 Hz, CHO), 7.26-7.44 (m, 5H, Ph), 5.94 (d, 1H, J = 5.2, Hz, CHONO2), 5.66-
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5.73 (m, 1H, CH=CH), 5.35-5.42 (m, 1H, CH=CH), 4.04-4.09 (m, 1H, CH-OMe), 3.21 
(s, 3H, OCH3), 2.36-2.46 (m, 3H, CHCHO, CH2CH=CH), 1.29-1.66 (m, 10H, 
(CH2)5CH3) 0.87-0.89 (m, 3H, CH3); 13C NMR (150 MHz, acetone-d6) δ 205.3, 135.9, 
130.29, 130.0, 129.7, 129.4, 129.1, 87.5, 83.9, 57.2, 52.3, 34.7, 32.8, 32.5, 30.0, 28.0, 
23.8, 14.9.  
 
tert-butyl 2-(1-hydroxyoctan-2-yl)-1H-pyrrole-1-carboxylate (Figure 3a):  A 
solution of the trifluoromethanesulfonic acid salt of (2S, 5S)-2-tert-butyl-5-benzyl-3-
methylimidazolidin-4-one (18.0 mg, 0.05 mmol) in DME (1 mL) was prepared in a 
scintillation vial equipped with a magnetic stir bar at –78 °C under argon. In this order, 
octanal (32 mg, 0.25 mmol), Boc-pyrrole (125.4 mg, 0.75 mmol), water (18 mg, 1.0 
mmol) and CAN (274.1 mg, 0.5 mmol) were added to this mixture. After purging the 
solution with argon for 1 minute, the reaction mixture was warmed to –30 °C and stirred 
for 12 hours until the reaction was judged to be complete by TLC. The cold reaction 
mixture was poured into diethyl ether and filtered through iatrobeads and concentrated in 
vacuo.  The resulting residue was dissolved in EtOH (3 mL), cooled to 0 °C and stirred 
with NaBH4 (19.0 mg, 0.5 mmol) for 1 hour.  The reaction was quenched by dropwise 
addition of saturated NH4Cl (5 mL) and the aqueous layer was extracted with Et2O (2× 5 
mL). The combined organic layers were dried over MgSO4, filtered and concentrated in 
vacuo. The residue was purified by flash column chromatography (10% ether/pentane) to 
provide the title compound as colorless oil (62 mg, 84% yield, 84 %ee). The 
enantiomeric ratio was determined by SFC analysis using a Chiralcel AD-H (25 cm × 
0.46 cm) column (5% to 50% MeOH, linear gradient, 100 bar, 35 °C oven, 4.0 mL/min); 
(R) isomer tr = 1.55 min and (S) isomer tr = 1.91 min. 1H NMR (500 MHz, CDCl3) δ 7.2 
(dd, 1H, J = 1.8, 3.4 Hz, pyrrole 5H), 6.12 (t, 1H, J = 3.4 Hz, pyrrole 3H), 6.07 (dd, 1H, J 
= 1.8, 3.4, Hz, pyrrole 4H), 3.7 (m, 3H, CH2OH & CH), 1.68 (m, 2H, CH2), 1.6 (s, 9H, 
C(CH3)3), 1.20-1.36 (m, 8H, CH2CH2CH2CH2CH2CH3), 0.87 (t, 3H, J = 7.0 Hz, CH3); 
13C NMR (75 MHz, CDCl3) δ 149.81, 136.95, 121.56, 110.77, 110.11, 83.72, 66.22, 
39.95, 31.76, 31.41, 29.52, 28.04, 27.27, 22.66, 14,11; [α]D= –9.6° (c = 1.5, CHCl3, 25 
°C).  
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(1R,2R,1'S)-2-(1'-Chloropropyl)cyclopentanecarbaldehyde (Figure 3b): A 25 
mL round bottomed flask equipped with a large magnetic stir bar was charged with LiCl 
(125 mg, 5.0 mmol, 5.0 equiv.) and catalyst 1 (42 mg, 0.12 mmol, 0.2 equiv.) in distilled 
acetone (10 ml, 0.0625M) and water (22 µl, 1.2 mmol, 2.0 equiv.). The resultant slurry 
was degassed at low temperature prior to being stirred at room temperature for 1 hour. 
The reaction mixture was then cooled to -20 °C, cis-6-nonenal (100 ml, 0.6 mmol, 1 
equiv.) added and Ceric Ammonium Nitrate (725 mg, 1.32 mmol, 2.2 equiv.) and the 
solvent degassed via an evacuation/argon flush which was performed three times, for a 
period of at least a minute each time. The hetereogenous reaction mixture was stirred at 
between -20 °C and -10 °C for 2 hours, ensuring constant agitation throughout the time 
period. No monitoring of the reaction was performed as exposure to either air or moisture 
resulted in a compromised yield of desired product. Upon completion the reaction 
mixture was diluted with Et2O to precipitate the catalyst, flushed through a small pad of 
fluorosil, eluting with Et2O and a small amount of acetone, and then concentrated in 
vacuo. The product was purified by silica gel chromatography (5% Et2O/pentane) to yield 
the title compound as a colourless oil (87 mg, 85% isolated yield, 95% ee for major 
diastereomer and 90% for minor, ≥8:1 dr) following silica gel chromatography (5% 
Et2O/pentane).   IR (film) 2963, 2873, 1721, 1452, 1218, 808, 668 cm-1; 1H NMR (300 
MHz, (CDCl3) Major diastereomer δ 1.04 (t, 3H, J = 7.5 Hz, -CH2CH3), 1.45-1.96 (m, 
8H, -CH2CH2CH2- and –CH2CH3), 2.69 (m, 1H, -CHCH(Cl)CH2-), 2.85 (m, 1H, -
CHC(O)H), 3.85 (ddd, 1H, J = 3.3, 6.6, 9.0 Hz, -CHCl), 9.71 (d, 1H, J = 2.1 Hz, -
C(O)H). Minor diastereomer δ 1.04 (m, 3H, -CH2CH3), 1.45-1.96 (m, 8H, -CH2CH2CH2- 
and –CH2CH3), 2.60 (m, 1H, -CHCH(Cl)CH2-), 2.80 (m, 1H, -CHC(O)H), 3.94 (ddd, 
1H, J = 4.5, 4.5, 9.0 Hz, - CHCl), 9.67 (d, 1H, J = 1.8 Hz, -C(O)H); 13C NMR (75 MHz, 
CDCl3) Major diastereomer δ 11.1, 25.8, 27.6, 30.4, 31.3, 46.5, 54.8, 69.8, 203.2. Minor 
diastereomer δ 11.7, 25.2, 27.4, 30.5, 31.3, 45.5, 55.2, 68.9, 203.1; HRMS (EI) exact 
mass calculated for (C9H15OCl) requires m/z 174.0811, found m/z 174.0813; [α]D = -
20.7º (c = 2.0, CHCl3); The enantiomeric ratio was determined by GLC using a Γ-TA 
column (100ºC isotherm for 160 minutes, 1 ml/min); major enantiomer tr= 45.75 min and 
minor enantiomer tr = 29.89 min. The diastereomeric ratio was determined by the same 
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assay; minor diastereomer, major enantiomer tr= 40.45 min and minor diastereomer, 
minor enantiomer tr= 33.49 min. 
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